Home > Category > Chiral Reagent > (4S,5S)-4,5-Diphenyl-4,5-dihydro-1H-imidazole

(4S,5S)-4,5-Diphenyl-4,5-dihydro-1H-imidazole

Daicel≥98%,99%e.e.

Catalog No：136482-1G CAS No.：NA MDLNo： Brand:Daicel purity：≥98%,99%e.e. 特性： Purpose:

Size	Availability	Price(USD)
1G	请咨询	$1050.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	(4S,5S)-4,5-Diphenyl-4,5-dihydro-1H-imidazole
CAS	NA
Formula	C₁₅H₁₄N₂

Related literature

Sorry, there is no relevant literature

201518-50MG

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

2409652-68-0 ≥95%,-

201494-1G

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

201494-100MG

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

201494-25MG

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

201493-1G

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

NA ≥95%,-

201493-100MG

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

NA ≥95%,-

201493-25MG

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

NA ≥95%,-

201464-100MG

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

NA ≥95%,-

201463-100MG

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

NA ≥95%,-

201460-100MG

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

NA ≥95%,-

History

GP20862-10μg

Prolactin Ovine Antagonist, Mutant

(4S,5S)-4,5-Diphenyl-4,5-dihydro-1H-imidazole

NA ≥98%,99%e.e.